Ignite Creation Date:
2024-05-05 @ 5:01 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00375713
Status:
COMPLETED
Last Update Posted:
2011-08-31
First Post:
2006-09-12
Brief Title:
Randomized Phase III Study to Evaluate the Efficacy and Safety of Xyzal Levocetirizine vs Zyrtec Cetirizine in Subjects With Dermatitis and Eczema
Sponsor:
UCB Pharma
Organization:
UCB Pharma
Study Overview
Official Title:
A Multi-centre Double-blind Double-dummy Randomized Active-controlled Phase III Study to Evaluate the Efficacy and Safety of Xyzal 5mg od vs Zyrtec 10mg od in Subjects Aged 15 Years and Above With Dermatitis and Eczema
Status:
COMPLETED
Status Verified Date:
2009-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Korean double-blind non-inferiority study to asses the efficacy as measured by the responder rate of pruritus severity score by the patient at visit 4 or end-of-treatment visit over the 2 weeks treatment period and safety of Xyzal to Zyrtec in subjects suffering from dermatitis and eczema with pruritus symptoms
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None